Swedish preventive-health company Neko Health has closed a $700 million Series C to bankroll its United States launch, valuing the Stockholm-based startup founded by Spotify co-founder Daniel Ek and CEO Hjalmar Nilsonne at close to $7 billion.
Lightspeed leads the healthtech round of the year
The July 15 round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with existing investors Atomico, General Catalyst and Lakestar rejoining alongside new backers Liberty City Ventures, Positive Sum and BDT & MSD. The round follows a $260 million Series B in January 2025 and takes total capital raised to roughly $1.2 billion. David Ofer of O.G. Venture Partners will take a board seat pending regulatory approval.
Full-body scans, in-house hardware, and a 350,000-person waitlist
Neko's flagship 60-minute Health Scan captures millions of data points across skin, blood, heart and body composition with proprietary Derma, Echo and Spectrum sensors, then walks members through the results in a same-visit clinician consultation for £299. The company says more than 100,000 people across Sweden and the United Kingdom have already been scanned and 350,000 more are on the waitlist, with 75% of members prepaying for the next year's scan on the spot.
NYC is Neko's first US clinic — with a Derma-2, Echo-2 hardware refresh
Neko will open its first US clinic in Manhattan later this year, entering a market where employers and payers are pouring money into preventive screening. Fresh capital will also fund the rollout of its second-generation Derma-2, Echo-2 and Spectrum-2 devices unveiled at Neko's newest Stockholm clinic last month and being deployed across the fleet over the coming months.
The raise lands the same week as another blockbuster health-tech ticket — Chai Discovery's $400M Series C — signaling that late-stage capital is again crowding into AI-enabled healthcare after a subdued 2024. It also comes as FDA-cleared AI diagnostics gain traction on both sides of the Atlantic.
Reporting based on coverage from Neko Health, TechCrunch, and FierceHealthcare.